Literature DB >> 27900021

Inhibition of PTTG1 expression by microRNA suppresses proliferation and induces apoptosis of malignant glioma cells.

Xing Su1, Jianguo Chen1, Lanchun Ni1, Wei Shi1, Jinlong Shi1, Xiaojiang Liu1, Yu Zhang1, Peipei Gong1, Hui Zhu2, Qingfeng Huang1.   

Abstract

The present study aimed to investigate the role of pituitary tumor-transforming gene 1 (PTTG1) in the proliferation, invasion and apoptosis of human malignant glioma U251 cells. Firstly, 2 microRNAs (miRNAs) targeting PTTG1 messenger (m)RNA were ligated into a pcDNA6.2-GW/EmGFP-miR expression vector. The recombinant plasmids, miRNA-1 and miRNA-2 (miR-2), were transfected into U251 cells using the liposome method. PTTG1 mRNA and protein levels were evaluated using quantitative polymerase chain reaction and western blot analysis. The proliferation and invasion abilities of U251 cells were determined using methylthiazol tetrazolium and Matrigel assays. Flow cytometry analysis with Annexin V/propidium iodide double staining was used to determine the percentage of apoptotic cells. PTTG1 expression was effectively suppressed by miR-2. U251 cell growth was inhibited between 10.7 and 34.7% in the miR-2 group compared with the blank group. The Matrigel assay demonstrated that the percentage of infiltrating U251 cells was significantly lower in the miR-2 group (12.3±1.0%) compared to the blank group (24.7±1.4%; P<0.001) and the negative control group (24.0±2.0%; P<0.05). A higher percentage of apoptotic U251 cells were observed in the miR-2 group compared with the blank group (53.6 vs. 32.4%) using flow cytometry due to cycle arrests at the G2/M phase. The miR-2-transfected U251 cells were subcutaneously injected into nude mice, and these mice possessed a decreased tumor tissue growth rate and higher percentage of apoptotic cells compared with the blank and negative control groups. In conclusion, PTTG1 gene expression in human malignant glioma U251 cells was effectively suppressed by exogenous miR-2. The downregulation of PTTG1 induced glioma cell apoptosis and cell cycle arrest at the G2/M phase, which inhibited cell proliferation, reverse invasion and infiltration of glioma cells.

Entities:  

Keywords:  PTTG1; cell apoptosis; cell proliferation; glioma; microRNAs; tumor invasion

Year:  2016        PMID: 27900021      PMCID: PMC5103968          DOI: 10.3892/ol.2016.5035

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  30 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Downregulation of Apaf-1 and caspase-3 by RNA interference in human glioma cells: consequences for erucylphosphocholine-induced apoptosis.

Authors:  W Kugler; F Buchholz; F Köhler; H Eibl; M Lakomek; B Erdlenbruch
Journal:  Apoptosis       Date:  2005-10       Impact factor: 4.677

3.  Expression of pituitary-tumour transforming gene in colorectal tumours.

Authors:  A P Heaney; R Singson; C J McCabe; V Nelson; M Nakashima; S Melmed
Journal:  Lancet       Date:  2000-02-26       Impact factor: 79.321

4.  Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

Authors:  Benjamin P Lewis; Christopher B Burge; David P Bartel
Journal:  Cell       Date:  2005-01-14       Impact factor: 41.582

5.  Structure, expression, and function of human pituitary tumor-transforming gene (PTTG).

Authors:  X Zhang; G A Horwitz; T R Prezant; A Valentini; M Nakashima; M D Bronstein; S Melmed
Journal:  Mol Endocrinol       Date:  1999-01

6.  Activation of mitogen-activated protein kinase cascade regulates pituitary tumor-transforming gene transactivation function.

Authors:  L Pei
Journal:  J Biol Chem       Date:  2000-10-06       Impact factor: 5.157

7.  Characterization of a polyclonal antibody to human pituitary tumor transforming gene 1 (PTTG1) protein.

Authors:  S S Kakar; L Chen; R Puri; S E Flynn; L Jennes
Journal:  J Histochem Cytochem       Date:  2001-12       Impact factor: 2.479

8.  Regulation of the pituitary tumor transforming gene by insulin-like-growth factor-I and insulin differs between malignant and non-neoplastic astrocytes.

Authors:  Kathrin Chamaon; Elmar Kirches; Dimitrios Kanakis; Stefan Braeuninger; Knut Dietzmann; Christian Mawrin
Journal:  Biochem Biophys Res Commun       Date:  2005-05-27       Impact factor: 3.575

9.  Regulation of pituitary tumor transforming gene (PTTG) expression and phosphorylation in thyroid cells.

Authors:  Gregory D Lewy; Gavin A Ryan; Martin L Read; Jim C W Fong; Vikki Poole; Robert I Seed; Neil Sharma; Vicki E Smith; Perkin P K Kwan; Sarah L Stewart; Andrea Bacon; Adrian Warfield; Jayne A Franklyn; Christopher J McCabe; Kristien Boelaert
Journal:  Endocrinology       Date:  2013-07-18       Impact factor: 4.736

10.  RNAi-mediated knockdown of pituitary tumor- transforming gene-1 (PTTG1) suppresses the proliferation and invasive potential of PC3 human prostate cancer cells.

Authors:  S Q Huang; Q J Liao; X W Wang; D Q Xin; S X Chen; Q J Wu; G Ye
Journal:  Braz J Med Biol Res       Date:  2012-08-09       Impact factor: 2.590

View more
  7 in total

1.  MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.

Authors:  Tongle Zhi; Kuan Jiang; Xiupeng Xu; Tianfu Yu; Weining Wu; Er Nie; Xu Zhou; Xin Jin; Junxia Zhang; Yingyi Wang; Ning Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

2.  The long non-coding RNA PTTG3P promotes growth and metastasis of cervical cancer through PTTG1.

Authors:  Xiang-Cui Guo; Li Li; Zhi-Hui Gao; Hong-Wei Zhou; Jun Li; Qian-Qing Wang
Journal:  Aging (Albany NY)       Date:  2019-03-10       Impact factor: 5.682

3.  Distinct expression pattern and prognostic values of pituitary tumor transforming gene family genes in non-small cell lung cancer.

Authors:  Shaolong Yang; Xiaodi Wang; Jingxing Liu; Bisha Ding; Kairi Shi; Jing Chen; Weiyang Lou
Journal:  Oncol Lett       Date:  2019-09-10       Impact factor: 2.967

4.  A flexible microfluidic system for single-cell transcriptome profiling elucidates phased transcriptional regulators of cell cycle.

Authors:  Karen Davey; Daniel Wong; Filip Konopacki; Eugene Kwa; Tony Ly; Heike Fiegler; Christopher R Sibley
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

5.  Clinical significance of securin expression in solid cancers: A PRISMA-compliant meta-analysis of published studies and bioinformatics analysis based on TCGA dataset.

Authors:  Xiang Liu; Wei Zeng; Dayang Zheng; Min Tang; Wangyan Zhou
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

6.  MicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2.

Authors:  Dejian Zhao; Wenzheng Han; Xia Liu; Dawei Cui; Yu Chen
Journal:  Thorac Cancer       Date:  2017-05-17       Impact factor: 3.500

7.  Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells.

Authors:  Juan de Los Santos-Jiménez; José A Campos-Sandoval; Clara Márquez-Torres; Nieves Urbano-Polo; David Brøndegaard; Mercedes Martín-Rufián; Carolina Lobo; Ana Peñalver; María C Gómez-García; Janet Martín-Campos; Carolina Cardona; Laura Castilla; Felipe da Costa Souza; Tzuling Cheng; Juan A Segura; Francisco J Alonso; Rui Curi; Alison Colquhoun; Ralph J DeBerardinis; Javier Márquez; José M Matés
Journal:  J Biomed Sci       Date:  2021-02-20       Impact factor: 8.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.